Medical cannabis is taking over Europe, as well as efforts to decriminalize cannabis in numerous countries and at local levels. In a pattern similar to what took place in the U.S., European nations are legalizing cannabis for medical or recreational purposes in a patchwork of new laws.

According to a May 16 press release from Victoria, Australia-based Biortica Agrimed, 21 out of 27 member states of the European Union (EU) legalized medical cannabis.

“The EU situation with respect to legalisation can best be described as fluid, but evolving positively,“ said Tom Varga, CEO of Biortica Agrimed. Biortica Agrimed is a vertically-integrated B2B company  preparing to list on the Australian Securities Exchange with an IPO.

The 27 EU countries are Austria, Belgium, Bulgaria, Croatia, Republic of Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain and Sweden.

Out of those, 21 countries—Austria, Belgium, Croatia, Republic of Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovenia, and Spain—implemented laws to allow for the medical use of cannabis.

Out of those countries, the potential market in Germany is among the most exciting and where investors are circling the most at the current moment.

“Whilst EU law prohibits the commercial sale of cannabis, many countries are taking a more mature approach, and legalising, initially medicinal, and ultimately personal use, with Germany in the lead. 21 out of the 27 EU member states have legalised use of medicinal cannabis,” he said, “and 13 countries have either legalised or decriminalised its personal use.”

Countries like Spain have decriminalized cannabis, while Georgia, Germany, Luxembourg, and Malta have taken steps to legalize adult-use. Countries like Portugal have gone even further by decriminalizing all drugs. Dozens more cities in the EU decriminalized cannabis at the city level.

Part of the purpose of Biortica Agrimed’s report is to support the argument that it’s due time Australia takes note of the potential Down Under. Australia legalized medical marijuana in 2016. According to Therapeutic Goods Administration (TGA) data, the number of patient approvals for medical cannabis increased sharply. In Australia, doctors can prescribe medicinal cannabis with the approval from the TGA and the relevant State or Territory’s Health Department.

“The EU comprises world class nations, and Australia should take any learnings that we can from the EU.” he said, “We have the benefit, and indeed the privilege, to view how legislative frameworks have been built over-seas, what’s worked and working, and what the Australian industry and legislators should avoid. Australia really can do better.”

“We look forward to continuing to share our global industry research with the Australian industry, our legislators and regulators, to build an industry that we can all be proud of, an industry that puts patient care, safety and outcomes to the fore, ” said Varga.

Cannabis Prevalence in Europe

Cannabis remains the most popular substance used in Europe according to the most recent counts by European data monitors.

The European Monitoring Centre for Drugs and Drug Addiction’s (EMCDDA) report, entitled “Cannabis—the current situation in Europe (European Drug Report 2023),” describes cannabis as “by far the most commonly consumed illicit drug in Europe.”

The report cites national surveys which show that 8% of European adults (out of approximately 22.6 million people between 15 and 64 years of age) have used cannabis within the last year. An estimated 1.3% of adults (approximately 3.7 million people) are described as “daily” or “almost daily” consumers.

With the popularity of cannabis continuing to grow, the report notes that this often leads to consumer “problems.” “There remains, however, a need to understand better the kinds of problems experienced by cannabis users, as well as the referral pathways and treatment options available for those with cannabis-related problems,” the report stated.

Germany’s legislation to legalize cannabis took effect on April 1. German lawmakers gave final approval to a recreational weed legalization plan known as CanG recently, making the country the largest in Europe to take the step.

In the German capital of Berlin, cannabis smokers gathered at the iconic Brandenberg Gate to smoke weed and celebrate their new freedoms. Other events were held throughout Europe’s most populous country, including one in front of the Cologne cathedral and others in the cities of Hamburg, Regensburg, and Dortmund.

The patchwork of laws unfolding in the EU show how medical and adult-use cannabis are popular on a global scale, and what Australia could learn from European countries.

The post Twenty-One of 27 European Union Countries Legalized Medical Cannabis, Report Highlights first appeared on High Times.

The post Twenty-One of 27 European Union Countries Legalized Medical Cannabis, Report Highlights appeared first on Paradise Found.

In early 2022 Dutch health authorities issued a warning about MDMA-laced champagne circulating throughout parts of Europe that hospitalized several people and killed one. An arrest has been made in connection with the case almost two years later, but authorities said there’s no way to know if additional bottles are still in circulation.

According to Dutch media outlet RTL Nieuws, police arrested a 35-year-old man last week in the German town of Weiden on drug trafficking and manslaughter charges in relation to MDMA-laced champagne bottles, the consumption of which reportedly hospitalized just under a dozen people and led to the death of a 52-year-old German man. MDMA, better known as “Molly” or “Ecstasy” is shorthand for 3,4-Methyl​enedioxy​methamphetamine, a drug which induces feelings of euphoria in the user for several hours. 

According to RTL Nieuws, the Polish man, whose name was not released, was arrested due to a tip from Dutch authorities. He allegedly stored the laced champagne bottles in the Netherlands and was also involved with their distribution, though not much other information about the man was released. A German news report said that the prosecutor’s office accused the man of  “gang-like trafficking in narcotics in large quantities, negligent bodily harm and negligent homicide.” Authorities said more arrests could be forthcoming as well. 

The Dutch Food and Consumer Product Safety Authority (NVWA) issued a warning about the champagne bottles, specifically 3-liter bottles of Moët and Chandon Ice Impérial, in February of 2022. A press release from the NVWA said the following:

“The Dutch Food and Consumer Product Safety Authority warns consumers to be very careful with 3-liter champagne bottles from the Moët & Chandon Ice Impérial brand. Recently, a bottle of that size appeared to be filled with the hard drug MDMA (also known as ecstasy) in both Germany and the Netherlands,” said a press release from the NVWA. “Touching and/or drinking the contents of the bottles is life-threatening. This has led to seven very serious cases of illness and one death in Germany. According to the producer, there were four cases of illness in the Netherlands. In both cases, the bottles in question were purchased via a previously unknown website.”

The NVWA clarified that it was somewhat easy to spot which bottles were potentially tainted with MDMA because the liquid did not come out carbonated as champagne does. The liquid did not fizz when poured, it came out a reddish brown color which darkened over time and also gave off a smell of the anise plant, which according to Google has similarities to the smells of licorice, fennel and tarragon. 

“The NVWA calls on people to be alert to 3 liter bottles of Moët & Chandon Ice Impérial with lot code LAJ7QAB6780004 and LAK5SAA6490005. This code can be found on the label on the back of the bottle,” the press release said.” Leave the bottle untouched if the contents differ from what is usual for champagne. Bottles filled with MDMA are indistinguishable on the outside from bottles filled with champagne. However, when pouring there is a clear difference.”

According to the NVWA, there’s no way to be sure how many more bottles, if any, were laced with MDMA and there’s no way to know if these bottles are still available in stores without checking the lot code on the back, as mentioned above. The health authority stressed that anyone who buys that brand of champagne should be on high alert, call emergency services if the liquid is ingested and call the police if anything seems off about a bottle. 

“It is not known how the MDMA ended up in these bottles. The NVWA cannot therefore estimate whether there are more of these bottles containing the hazardous substance in circulation, the press release said. “It cannot be ruled out that there are other bottles of the same brand in circulation that also contain MDMA”

According to the aforementioned German news report, the seven people who were hospitalized were out having a celebratory dinner with friends when they bought the tainted champagne. The report described everyone fainting at the table after the champagne was brought out. The 52-year-old who died had reportedly drank more of the champagne than the others, who had only sipped it. All seven people reportedly made full recoveries and attended a memorial for their deceased friend in February. 

The post Polish Man Arrested in Germany for Hospitalizations, Death Caused by MDMA-Laced Champagne appeared first on High Times.

The post Polish Man Arrested in Germany for Hospitalizations, Death Caused by MDMA-Laced Champagne appeared first on Paradise Found.

The post Poland Pushes On: Cannabis Reform Is A Game of Inches appeared first on Paradise Found.